Okay, attention-grabbing title out of the way… I just finished reading the review paper "LDL-C Does Not Cause Cardiovascular Disease" from Expert Review in Clinical Pharmacology,
PDF of manuscript available free through researchgate. And based on that paper, and the response I've seen to the PCSK-9 article in NEJM, I can't help but wonder, what's the future of lipid lowering meds. I'm an incoming IM PGY-1, just looking to do right by my future patients.
My question to you all is, what is your current approach to prescribing and targeting TC, LDL? And what's your reasoning.
Edit: Thank you all for your replies, this is what I was hoping to see. I am not trying to be a "problem intern" or any dumb shit like that. I posted this because I do not want to blindly practice based on whatever was in a textbook when I'm graduating. I wanted to know where the discussion currently is. I will check out that JAMA article and appreciate all of you who posted other research articles (and will take a look at them as well). Thanks for your inputs (sincerely).
Source: Original link
